Skip to main content
Caplight Logo









FreeOx Biotech

FreeOx Biotech

Private
BarcelonaHealthcare & Life Scienceshttps://freeoxbiotech.com/

Last Round

Crowdfunding

Jan 31, 2026

Est. Valuation

$20.6M

Total Funding Raised

$5.39M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

FreeOx Biotech is a biotechnology company that develops cerebrovascular protective therapies designed to reduce the effects of oxidative stress related to the neurological and cardiovascular systems.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

AIS treatmentstroke drugneuroprotective therapycerebroprotective therapyreperfusion injurythrombectomy adjunctclinical stage biotechdrug developmentNIH sponsored trialbiotech licensinguric acid formulationliposomal formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FreeOx Biotech Comparables

Compare FreeOx Biotech with similar companies based on industry and business-model similarity.

FreeOx Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
aptaTargets
88%
NoNO Inc.
84%
Argenica Therapeutics
79%

FreeOx Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJan 31, 2026
SeedDec 5, 2023
AngelNov 8, 2018
GrantAug 9, 2018

Key People

Founding team and executive leadership

Julian Penya

Interim CFO

Executive Team

FreeOx Biotech Investors

Notable investors and investment history

FreeOx Biotech investors
InvestorRounds
EIT HealthGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 50% MoM.

  • Jan 31, 2026

    Raised $3M led by Neurotechnology Investors.

FreeOx Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

FreeOx Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about FreeOx Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range6
Year Founded2017
Last FundingJan 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?